The Reports & Analysis application offers services for the following markets in the pharmaceutical industry:
EU (FMD)
When the user scans a pack for verification against the NMVS (Arvato) in the Serialized Logistics application, the scanned data is stored. The Reports & Analysis application enables the users to view the FMD scans performed in the warehouses.
The Reports & Analysis application is integrated with the EMVO Alert Management System (AMS) and lists the alerts for a time window not longer than one month. As a prerequisite, Movilitas.Cloud team configures an EU Hub channel and sets up the connection to the EMVO AMS for your tenant. The customer must have separate credentials for the EU Hub and for the EMVO AMS.
When the user performs an FMD action in bulk towards the NMVS (Arvato) in the Serialized Logistics application, a bulk transaction is created in the NMVS and a bulk response is retrieved from the NMVS. Once the bulk transaction check is finished and the bulk response is available, Movilitas.Cloud sends an email to all administrators of the tenant and to the operator who performed the FMD action. The Reports & Analysis application enables the users to view the bulk responses.
Bahrain / United Arab Emirates
Each transfer that the user performs as a 3PL in the Serialized Logistics application is stored. The Reports & Analysis application enables the user to generate a “total count” report about the scans performed for a supplier (MAH) in a given month. The user can download the file, send the file to an email address, or perform both actions at the same time. The report is in CSV format.
USA (DSCSA)
The requests are stored when a distributor sends VRS requests using the Product Verification DSCSA application. The Reports & Analysis application enables the users to view the VRS requests.
When a manufacturer sends VRS responses to incoming VRS requests by using the Serialized Manufacturing application, the responses are stored. The Reports & Analysis application enables the users to view the VRS responses.